Final-Program-ATS-2023-AP.vp

192

MONDAY • MAY 22

NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH OUTSIDE ORGANIZATION SESSION

DIVISION OF LUNG DISEASES, NHLBI/NIH OUTSIDE ORGANIZATION SESSION

L12 THE MOLECULAR ATLAS OF LUNG DEVELOPMENT (LUNGMAP), PHASE 2 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 204 A-C (Level 2) Target Audience Providers of lung health, medical fellows in training, and basic and clinical researchers interested in lung biology, developmental biology, pediatric lung disease pathogenesis, bioinformatics, and systems biology Objectives At the conclusion of this session, the participant will be able to: • learn the newest datasets of LungMAP that could inform lung research • learn the innovative technologies for molecular profiling, imaging, and data analysis of the developing lung. • learn how to access and use the LungMAP resources Molecular Atlas of Lung Development (LungMAP) is an NHLBI-sponsored program. The overall goal of this program is to establish an open-access reference resource by creating a comprehensive molecular atlas of the late-stage developing human lung with data and reagents available to the research community. Speakers will demonstrate how systems biology and bioinformatic approaches can be used to inform processes in development that are recapitulated in disease and repair. The session will illustrate the LungMAP data pipeline which integrates high resolution multi-omics and imaging data. Chairing: S. Lin, PhD, Bethesda, MD N. Salomonis, PhD, Cincinnati, United States 12:00 Post-Natal Development of Human Lung Cell Niches M.C. Basil, MD, PhD, Philadelphia, PA 12:12 Applying Single Nuclear Transcriptomics for Study of Rare Pulmonary Disorders in Infants and Children K.A. Wikenheiser-Brokamp, MD, PhD, Cincinnati, OH 12:24 Single Cell Profiling of Human Bronchopulmonary Dysplasia X. Sun, PhD, San Diego, CA 12:36 Multi-Omics Spatial Molecular Profiling of the Human Lung G.C.D. Clair, PhD, Richland, WA 12:48 LungMAP Consortium Assay Breadth in Coordinated Use of Human Tissue Core Biorepository Samples R. Misra, PhD, Rochester, NY

L11 DISPARITIES IN WORK-RELATED RESPIRATORY DISEASE 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 147 A-B (Street Level) Target Audience Providers of lung health; those interested in prevention of occupational respiratory disease. Objectives At the conclusion of this session, the participant will be able to: • better identify common pitfalls in race and ethnicity reporting in the occupational respiratory health literature and describe approaches to race and ethnicity data collection and analysis that can improve understanding of health disparities. • learn updated findings about work-related disparities in COVID-19. • understand considerations in selecting the appropriate sex to use in spirometry reference equations for interpreting results from transgender and gender-diverse people. The session will provide an update on current issues in work-related respiratory disease disparities. It will address the status of race and ethnicity reporting in occupational respiratory health and considerations for approaches to data collection and reporting to improve our understanding of racial or ethnic disparities and to better contextualize findings. It will also address disparities in occupations at risk for work-related COVID-19 and considerations in selecting appropriate spirometry test reference sex for transgender and gender-diverse people. Chairing: D.N. Weissman, MD, ATSF, Morgantown, WV 12:00 Introduction to Session D.N. Weissman, MD, ATSF, Morgantown, WV 12:03 Status of Race and Ethnicity Reporting in Occupational Respiratory Healt A.M. Foreman, PhD, Morgantown, WV 12:22 Work-Related COVID-19 Disparities J.M. Cox-Ganser, PhD, Morgantown, WV 12:41 Selecting Appropriate Spirometry Reference Sex for Gender-Diverse People E. Fechter-Leggett, DVM, MPVM, Morgantown, WV

ATS 2023 • Washington, DC